维普期刊资源整合服务平台（V6.5）

125篇 您的检索式：作者名="CAVO M"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study 显示文摘	Cavo M Tosi P Zamagni E	2007	Clin Oncol2007，25，：	1
2	Bortezomib thalidomide- dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma显示文摘	Cavo M Pantani L Petrucci MT	2012	Blood2012，120，1：	1
3	Prospective,randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma:Bologna 96 clinical study显示文摘	Cavo M Tosi P Zamagni E	2007	J Clin Oncol2007，25，17：	1
4	Superiority of thalidomide and dexamethasone over vincfistine - doxorubicin - dexamethasone as primary therapy in preparation for autologous transplantation for multiple myeloma 显示文摘	Cavo M Zamagni E Tosi P	2005	Blood2005，106，1：	1
5	Clinical outcome of extramed- ullary plasmacytoma显示文摘	Galieni P Cavo M Pulsoni A	2000	Haematologica2000，85，1：	1
6	Bortezomib with thalidomide plus dexamethasone compared with thalido- mide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem- cell transplantation in newly diagnosed multiple myelo- ma:a randomised phase 3 study 显示文摘	Cavo M Tacchetti P Patriarca F	2010	Lancet2010，376，9758：	1
7	Superiority of thalidomide and dexamethasone over vineristine-doxorubiein dexametha sone(VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma显示文摘	Cavo M Zamagni E Tosi P	2005	Blood2005，106，1：	1
8	Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma显示文摘	Cavo M Zamagni E Tosi P	2005	Blood2005，106，1：	1
9	Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-1993 and 1994-1998 at European Group for Blood and Marrow Transplantation centres显示文摘	Gahrton G Svensson H Cavo M	2001	Br J Haematol2001，113，1：	1
10	Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma显示文摘	Cavo M Zamagni E Tosi P	2005	{H}Blood2005，，01：	1
11	Prospective randomized study of single compared with double autologous stem cell transplantation for multiple myeloma: Bologna 96 clinical study显示文摘	Cavo M Tosi P Zamagni E	2007	J Clin Oncol2007，25，：	1
12	The changing landscape of myeloma therapy显示文摘	Cavo M Baccarani M	2006	N Engl J Med2006，354，10：	1
13	Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomide-dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘	Cavo M Tacchetti P Patriarca F	2008	Blood2008，112，11：	1
14	Progress in allogeneic bone marrwo and peripheral blood stem cell transplantation for multiple myeloma:a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation Centres显示文摘	Gahrton G Svensson H Cavo M	2001	Br J Haemato2001，113，：	1
15	Superiority of thalidomide and dexarnethsone over vineristine-doxorubieine-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma显示文摘	Cavo M Zamagni Tosi P	2005	Blood2005，106，：	1
16	Clinical outcome of extramedullary plasmacytoma显示文摘	Cavo M Pulsoni A Galieni P	2000	Haematologica2000，85，1：	1
17	Superiority of thalidomide and dexamethasone over vincristine-doxorubic in dexamethasone(VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma显示文摘	Cavo M Zamagni E Tosi P	2005	Blood2005，106，1：	1
18	Combination of international scoring system 3, high lactate dehydrogenase, and t (4; 14) and/or del (17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death 显示文摘	Moreau P Cavo M Sonneveld P	2014	J Clin Oncol2014，32，20：	1
19	Superiority of thalidomide and dexamethasone over vincristine - doxorubicin - dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma显示文摘	Cavo M Zamagnie E Tosi P	2005	B/ood2005，106，：	1
20	The role of imaging techniques in the management of multiple myeloma 显示文摘	Zamagni E Cavo M	2012	Br J Haematol2012，159，5：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示